P. H. Petersen

发表

The introduction of low-cost polyethylene tube biodigesters on small-scale farms in Vietnam.

F. Dolberg, T. R. Preston, Bui Xuan An, 1997 .

Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots.

P H Petersen, T Lauritzen, E D Lund, 1997, Clinical chemistry.

Upper reference limit, analytical quality specifications and clinical use of haemoglobin A1C

P. H. Petersen, I. Brandslund, N. Klitgaard, 2002, Scandinavian journal of clinical and laboratory investigation.

Analytical performance characteristics should be judged against objective quality specifications.

P. H. Petersen, C. Fraser, P. Petersen, 1999, Clinical chemistry.

Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor.

P. H. Petersen, M. Hørder, F. V. von Eyben, 1988, The Journal of urology.

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer

Catharine M. Sturgeon, Robert C. Bast, Per Hyltoft Petersen, 2015, International Journal of Gynecologic Cancer.

Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?

P. H. Petersen, I. Brandslund, K. Borch-Johnsen, 2002, Scandinavian journal of clinical and laboratory investigation.

Graphical interpretation of confidence curves in rankit plots

P. H. Petersen, K. Schousboe, L. Jørgensen, 2004, Clinical chemistry and laboratory medicine.

7. Reference Intervals for Plasma Proteins 7.1 Principles for Estimation of Reference Intervals

P. H. Petersen, O. Blaabjerg, 1994 .

Sampling time is important but may be overlooked in establishment and use of thyroid-stimulating hormone reference intervals.

P. H. Petersen, L. Hegedüs, O. Blaabjerg, 2007, Clinical chemistry.

Reference values: from philosophy to a tool for laboratory medicine

P. H. Petersen, J. Henny, P. Petersen, 2004, Clinical chemistry and laboratory medicine.

Assessment of CA 15.3, CEA and TPA Concentrations during Monitoring of Breast Cancer

P. H. Petersen, P. Dombernowsky, G. Sölétormos, 2000, Clinical Chemistry and Laboratory Medicine.

External quality assessment: currently used criteria for evaluating performance in European countries, and criteria for future harmonization.

P. H. Petersen, D. Stockl, L. Thienpont, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

6.1.2.2 Quality Specifications for Haemoglobin A1c Assays in the Monitoring of Diabetes

P. H. Petersen, M. L. Larsen, C. Fraser, 1993 .

The basis for common reference intervals for serum potassium.

P. H. Petersen, S. Vadstrup, M. S. Djurhuus, 1993, Upsala journal of medical sciences.

4. Guidelines for Assessing Analytical Quality Requirements

P. H. Petersen, T. Groth, C. Verdier, 1993 .

Principles for assessing analytical quality specifications ("AQSpecs") and their use in design of control systems.

P. H. Petersen, T. Groth, C. D. de Verdier, 1993, Upsala journal of medical sciences.

Influence of Analytical Quality on Test Results

P. H. Petersen, M. Hørder, P. Petersen, 1992 .

The Effect of the New ADA and WHO Guidelines on the Number of Diagnosed Cases of Diabetes Mellitus

Ivan Brandslund, Per Hyltoft Petersen, P. H. Petersen, 2003, Clinical chemistry and laboratory medicine.

Glycemic control in diabetes in three Danish counties

P. H. Petersen, I. Brandslund, H. Møller, 2005, Clinical chemistry and laboratory medicine.

Consequences Of Bias and Imprecision in Measurements of Glucose and Hba1c for the Diagnosis and Prognosis of Diabetes Mellitus

P. H. Petersen, I. Brandslund, L. Jørgensen, 2005, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Characterization and classification of external quality assessment schemes (EQA) according to objectives such as evaluation of method and participant bias and standard deviation. External Quality Assessment (EQA) Working Group A on Analytical Goals in Laboratory Medicine.

C Ricós, C G Fraser, P H Petersen, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Desirable performance standards for imprecision and bias in alternate sites. The views of laboratory professionals.

P. H. Petersen, C. Fraser, P. Petersen, 1995, Archives of pathology & laboratory medicine.

The clinical impact of screening for gestational diabetes

P. H. Petersen, I. Brandslund, L. Jørgensen, 2004, Clinical chemistry and laboratory medicine.

Authors' reply

P. H. Petersen, I. Brandslund, L. Jørgensen, 2006 .

Comments on 'HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose'.

P. H. Petersen, I. Brandslund, L. Jørgensen, 2006, Annals of clinical biochemistry.

THYROGLOBULIN OF VARYING MOLECULAR SIZES WITH DIFFERENT DISAPPEARANCE RATES IN PLASMA FOLLOWING SUBTOTAL THYROIDECTOMY

P. H. Petersen, U. Feldt-Rasmussen, J. Date, 1978, Clinical endocrinology.

Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter

P. H. Petersen, U. Feldt-Rasmussen, J. Date, 1982, Journal of endocrinological investigation.

A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women

P. H. Petersen, S. Sandberg, A. Kristoffersen, 2012, Annals of clinical biochemistry.

Changing from glucose to HbA1c for diabetes diagnosis: predictive values of one test and importance of analytical bias and imprecision

P. H. Petersen, I. Brandslund, A. Green, 2014, Clinical chemistry and laboratory medicine.

Plasma enzymes in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information.

P. H. Petersen, K. Thygesen, M. Hørder, 1981, Scandinavian journal of clinical and laboratory investigation.

Biological variation: Evaluation of methods for constructing confidence intervals for estimates of within-person biological variation for different distributions of the within-person effect.

P. H. Petersen, S. Sandberg, Bård Støve, 2017, Clinica chimica acta; international journal of clinical chemistry.

Criteria to interpret cancer biomarker increments crossing the recommended cut-off compared in a simulation model focusing on false positive signals and tumour detection time.

P. H. Petersen, G. Sölétormos, M. Pedersen, 2014, Clinica chimica acta; international journal of clinical chemistry.

Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials.

P. H. Petersen, S. Sandberg, A. Stavelin, 2009, Thrombosis and haemostasis.

Serum immunoglobulin M, G, and A concentration levels in Turner's syndrome compared with normal women and men

P. H. Petersen, J. Nielsen, K. Jensen, 1976, Human Genetics.

Reference intervals based on hospitalized 'healthy' patients and medical students in relation to analytical bias for serum potassium.

P. H. Petersen, S. Vadstrup, M. S. Djurhuus, 1992, Scandinavian journal of clinical and laboratory investigation.

Soluble CD163: a marker molecule for monocyte/macrophage activity in disease

P. H. Petersen, S. Moestrup, H. Møller, 2002, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies

P. H. Petersen, L. Hegedüs, K. Kyvik, 2004, Clinical chemistry and laboratory medicine.

4.3. Influence of analytical quality on the diagnostic power of a single S-CK B test in patients with suspected acute myocardial infarction

P. H. Petersen, T. Groth, M. Hørder, 1980 .

Studies on the required analytical quality of TSH measurements in screening for congenital hypothyroidism.

P. H. Petersen, F. Rosleff, J. Rasmussen, 1980, Scandinavian journal of clinical and laboratory investigation. Supplementum.

The influence of analytical bias on diagnostic misclassifications.

T Groth, C H de Verdier, C G Fraser, 1997, Clinica chimica acta; international journal of clinical chemistry.

Desirable standards for laboratory tests if they are to fulfill medical needs.

P. H. Petersen, C. Fraser, P. Petersen, 1993, Clinical chemistry.

6.1.2.3 Prenatal Screening for Neural Tube Defects, Quality Specification for Maternal Serum Alphafetoprotein Analysis

P. H. Petersen, B. No̸rgaard-Pedersen, J. Arends, 1993 .

The Importance of Imprecision

P. H. Petersen, C. Fraser, P. Petersen, 1991, Annals of clinical biochemistry.

Ways of assessing quality goals for diagnostic tests in clinical situations.

P. H. Petersen, M. Hørder, P. Petersen, 1988, Archives of Pathology & Laboratory Medicine.

Setting quality standards in clinical chemistry: can competing models based on analytical, biological, and clinical outcomes be harmonized?

P. H. Petersen, C. Fraser, P. Petersen, 1994, Clinical chemistry.

Acute beta-blockade changes the extracellular distribution of thyroid hormones

P. H. Petersen, H. Perrild, L. Skovsted, 1990, Journal of endocrinological investigation.

Effect of a new international reference preparation for proteins in human serum (certified reference material 470) on results of the College of American Pathologists Surveys for plasma proteins.

P. H. Petersen, A. M. Johnson, J. Whicher, 2000, Archives of pathology & laboratory medicine.

Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls.

P. H. Petersen, S. Sandberg, E. Svarstad, 2014, Clinical chemistry.

Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria.

P. H. Petersen, S. Sandberg, A. Aarsand, 2006, Clinical chemistry.

Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality

P. H. Petersen, C. Ricós, N. Iglesias, 2005, Clinical chemistry and laboratory medicine.

Influence of Index of Individuality on False Positives in Repeated Sampling from Healthy Individuals

P. H. Petersen, S. Sandberg, C. Fraser, 2001, Clinical chemistry and laboratory medicine.

Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer.

P. H. Petersen, P. Dombernowsky, G. Sölétormos, 1999, Gynecologic oncology.

Monitoring performance of progression assessment criteria for cancer antigen 125 among patients with ovarian cancer compared by computer simulation.

P. H. Petersen, G. Sölétormos, D. Nielsen, 2015, Biomarkers in medicine.

Variations in plasma protein concentrations in individuals with ulcerative colitis: analytical and biological factors.

P. H. Petersen, U. Feldt-Rasmussen, V. Binder, 1979, Scandinavian journal of clinical and laboratory investigation.

Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests

P. H. Petersen, T. Sørensen, K. Kyvik, 2002, Scandinavian journal of clinical and laboratory investigation.

Biological description of the cortisol responses to corticotropin-releasing-hormone (CRH) stimulation. An optimization and simplification of the test.

P. H. Petersen, C. Hagen, E. Grodum, 1993, Upsala journal of medical sciences.

Effect of increased gene dosage expression on the α-interferon receptors in Down's syndrome

P. H. Petersen, A. Gerdes, M. Hørder, 1993 .

Praecordial ECG mapping in acute anterior myocardial infarction. The evolution of ST segment and Q and R waves.

P. H. Petersen, K. Thygesen, M. Hørder, 2009, Acta medica Scandinavica.

Clinical outcome estimates based on treatment target limits of laboratory tests: proposal for a plot visualizing effects and differences of medical target setting exemplified by glycemic control in diabetes

P. H. Petersen, I. Brandslund, L. Jørgensen, 2006, Clinical chemistry and laboratory medicine.

Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men.

P. H. Petersen, R. Larsen, C. Hagen, 2007, The Journal of clinical endocrinology and metabolism.

Confirmation of analytical performance characteristics required for the reference change value applied in patient monitoring

P. H. Petersen, C. Fraser, G. Sölétormos, 2015, Scandinavian journal of clinical and laboratory investigation.

Combination of Analytical Quality Specifications Based on Biological Within- and Between-Subject Variation

P. H. Petersen, I. Brandslund, L. Jørgensen, 2002, Annals of clinical biochemistry.

5.1 External Analytical Quality Assurance for Proteins

P. H. Petersen, K. Irjala, K. Bjøro, 1993 .

GENETIC INFLUENCE ON THE SERUM LEVELS OF NATURALLY OCCURRING HUMAN IGG ANTIBODIES TO DIETARY ANTIGENS: QUANTITATIVE ASSESSMENT FROM A TWIN STUDY

P. H. Petersen, S. Husby, F. Schultz Larsen, 1987, Journal of immunogenetics.

The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin

P. H. Petersen, Grete Monsen, S. Sandberg, 2014, Scandinavian journal of clinical and laboratory investigation.

[A randomized controlled trial of the use of CRP rapid test as a guide to treatment of respiratory infections in general practice].

P. H. Petersen, J. Kragstrup, A. Munck, 2001, Ugeskrift for laeger.

Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice.

P. H. Petersen, J. Kragstrup, A. Munck, 2000, Scandinavian journal of primary health care.

Terms and symbols used in studies on biological variation: the need for harmonization.

P. H. Petersen, A. Šimundić, C. Fraser, 2015, Clinical chemistry.

Importance of the choice of assumptions and models in the estimation of analytical quality specifications

P. H. Petersen, 2002 .

Biological variation at long-term renal post-transplantation.

P. H. Petersen, R. Lauzurica, C. Ricós, 2006, Clinica chimica acta; international journal of clinical chemistry.

Calibration, Specificity and Trueness of a Postheparin Plasma Lipoprotein Lipase Assay

P. H. Petersen, H. Beck-Nielsen, F. Henriksen, 2001, Clinical chemistry and laboratory medicine.

Creatine kinase and creatine kinase B‐subunit in stable and unstable angina pectoris

P. H. Petersen, K. Thygesen, T. Haghfelt, 1986, European Journal of Clinical Investigation.

Plasma creatinine medians from patients partitioned by gender and age used as a tool for assessment of analytical stability at different concentrations

P. H. Petersen, C. Fraser, S. I. Hansen, 2019, Clinical chemistry and laboratory medicine.

Fasting and Post-Glucose Load – Reference Limits for Peripheral Venous Plasma Glucose Concentration in Pregnant Women

P. H. Petersen, I. Brandslund, L. Jørgensen, 2003, Clinical chemistry and laboratory medicine.

Errors in Enzymatic Estimation of Myocardial Infarct Size due to Changes in Plasma Volume

P. H. Petersen, K. Thygesen, M. Hørder, 1978 .

Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation.

P. H. Petersen, I. Brandslund, B. Dahler-Eriksen, 1998, Thrombosis research.

Concentration of fibrin monomer in pregnancy and during the postpartum period

P. H. Petersen, S. Sandberg, L. Bjørge, 2019, Annals of clinical biochemistry.

Different percentages of false-positive results obtained using five methods for the calculation of reference change values based on simulated normal and ln-normal distributions of data

P. H. Petersen, C. Fraser, G. Sölétormos, 2016, Annals of clinical biochemistry.

Week-to-week biological variation in the N-terminal prohormone of brain natriuretic peptide in hemodialysis patients and healthy individuals.

P. H. Petersen, S. Sandberg, E. Svarstad, 2013, Clinical chemistry.

On establishment of common reference intervals in laboratory medicine.

P. H. Petersen, L. Thienpont, C. Fraser, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Praecordial ECG-mapping in acute anterior myocardial infarction: the variability of ST segment, Q and R waves.

P. H. Petersen, K. Thygesen, M. Hørder, 1980, Scandinavian journal of clinical and laboratory investigation.

Biological variation of serum and urinary magnesium in apparently healthy males.

P. H. Petersen, H. Beck-Nielsen, J. Bollerslev, 1995, Scandinavian journal of clinical and laboratory investigation.

Lack of indication of myocardial cell damage after myocardial ischaemia in patients with severe stable angina.

P. H. Petersen, K. Egstrup, T. Haghfelt, 1992, European heart journal.

Plasma enzymes in myocardial infarction Application of a two-compartment model in assessing myocardial release of enzyme

P. H. Petersen, K. Thygesen, M. Hørder, 1981 .

Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000

P. H. Petersen, P. Rustad, A. Uldall, 2004, Scandinavian journal of clinical and laboratory investigation.

Quality improvement in wellness reports in patients with Crohn’s disease

P. H. Petersen, I. Brandslund, H. Grønbæk, 2006 .

Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women

P. H. Petersen, S. Sandberg, L. Bjørge, 2018, Clinical chemistry and laboratory medicine.

Partitioning of nongaussian-distributed biochemical reference data into subgroups.

Petter Laake, Per Hyltoft Petersen, P. H. Petersen, 2004, Clinical chemistry.

Serum thyroglobulin (Tg) in the follow-up of differentiated thyroid cancer after thyroid ablation.

P. H. Petersen, U. Feldt-Rasmussen, J. Date, 1980, Clinical endocrinology.

An improved co-precipitation assay for determination of thyroglobulin antibodies.

P. H. Petersen, U. Feldt-Rasmussen, J. Date, 1980, Scandinavian journal of clinical and laboratory investigation.

SEQUENTIAL CHANGES IN SERUM THYROGLOBULIN (Tg) AND ITS AUTOANTIBODIES (TgAb) FOLLOWING SUBTOTAL THYROIDECTOMY OF PATIENTS WITH PREOPERATIVELY DETECTABLE TgAb

P. H. Petersen, U. Feldt-Rasmussen, J. Date, 1980, Clinical endocrinology.

SERUM THYROGLOBULIN IN ACUTE AND CHRONIC LIVER DISEASE

P. H. Petersen, L. Hegedüs, J. Kastrup, 1983, Clinical endocrinology.

LETTER TO THE EDITORS

P. H. Petersen, U. Feldt-Rasmussen, 1980 .

Biological Variation: The Effect of Different Distributions on Estimated Within-Person Variation and Reference Change Values.

P. H. Petersen, S. Sandberg, Bård Støve, 2016, Clinical chemistry.

Gastric Function Tests Correlated to A B H Blood Group Substances in Gastric Juice

P. H. Petersen, P. Rødbro, K. Fischermann, 1967 .

LACTATE DEHYDROGENASE ISOENZYME 1 IN TESTIS CANCER

P. H. Petersen, M. Hørder, O. Blaabjerg, 1987, The Lancet.

Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Seminoma Stage I Followed with Surveillance

P. H. Petersen, L. Specht, G. Jacobsen, 2002, Acta oncologica.

Serum lactate dehydrogenase isoenzyme 1 activity in patients with testicular germ cell tumors correlates with the total number of copies of the short arm of chromosome 12 in the tumor

P. H. Petersen, D. Sleijfer, J. Oosterhuis, 1992, Molecular and General Genetics MGG.

Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.

P. H. Petersen, F. V. von Eyben, O. Blaabjerg, 1992, European journal of cancer.

Characterization and classification of external Quality Assessment Schemes (EQA) according to objectives such as evaluation of method and participant bias and standard deviation

Carmen Ricós, Jean-Claude Libeer, Callum G. Fraser, 1996 .

Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Testicular and Ovarian Germ Cell Tumours

P. H. Petersen, M. Mirza, O. Blaabjerg, 2002 .

Lactate dehydrogenase isoenzyme 1 in testicular germ cell tumors.

P. H. Petersen, F. Kirpekar, S. Mommsen, 1991, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

6.1.1.3 Analytical Bias by Contamination from Hemolysis in Determination of Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Testis Germ Cell Tumors

P. H. Petersen, B. No̸rgaard-Pedersen, O. Blaabjerg, 1993 .

A prospective study of the differential changes in serum thyroglobulin and its autoantibodies during propylthiouracil or radioiodine therapy of patients with Graves' disease.

P. H. Petersen, K. Johansen, U. Feldt-Rasmussen, 1982, Acta endocrinologica.

Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period

P. H. Petersen, G. Sölétormos, D. Nielsen, 2017, Future science OA.

Estimates of Within-Subject Biological Variation of Protein C, Antithrombin, Protein S Free, Protein S Activity, and Activated Protein C Resistance in Pregnant Women.

P. H. Petersen, S. Sandberg, T. Røraas, 2017, Clinical chemistry.

Proposals for Setting Generally Applicable Quality Goals Solely Based on Biology

Jean-Claude Libeer, Per Hyltoft Petersen, Callum G Fraser, 1997, Annals of clinical biochemistry.

Desirable routine analytical goals for quantities assayed in serum. Discussion paper from the members of the external quality assessment (EQA) Working Group A on analytical goals in laboratory medicine.

C Ricós, C G Fraser, P H Petersen, 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Graphical interpretation of analytical data from comparison of a field method with reference method by use of difference plots.

P H Petersen, D Stöckl, L Thienpont, 1997, Clinical chemistry.

Should we maintain the 95 percent reference intervals in the era of wellness testing? A concept paper

P. H. Petersen, I. Brandslund, L. Jørgensen, 2004, Clinical chemistry and laboratory medicine.

Reference intervals for plasma proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK

P. H. Petersen, S. Maclennan, A. M. Johnson, 2004, Clinical chemistry and laboratory medicine.

Improved sensitivity of a thyrotropin receptor antibody assay.

P. H. Petersen, L. Hegedüs, O. Blaabjerg, 2005, Clinical chemistry.

Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population

P. H. Petersen, K. Kyvik, N. Holm, 2002, BMJ : British Medical Journal.

Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice.

P. H. Petersen, R. Lamerz, A. Semjonow, 2005, Clinical chemistry.

Interpretation of increments in serial tumour biomarker concentrations depends on the distance of the baseline concentration from the cut-off

P. H. Petersen, G. Sölétormos, M. Pedersen, 2011, Clinical chemistry and laboratory medicine.

Prerequisites for establishing common reference intervals

P. H. Petersen, P. H. Petersen, P. Rustad, 2004, Scandinavian journal of clinical and laboratory investigation.

External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials.

Sverre Sandberg, Per Hyltoft Petersen, Anne Stavelin, 2013, Clinical chemistry.

Serum lactate dehydrogenase isoenzyme 1 and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I.

P. H. Petersen, M. Ro̸rth, G. Jacobsen, 2001, Acta oncologica.

Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry.

C G Fraser, P H Petersen, R Haeckel, 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Separate patient serum sodium medians from males and females provide independent information on analytical bias

P. H. Petersen, C. Fraser, G. Sölétormos, 2017, Clinical Chemistry and Laboratory Medicine.

Median of patient results as a tool for assessment of analytical stability.

Per Hyltoft Petersen, György Sölétormos, P. H. Petersen, 2015, Clinica chimica acta; international journal of clinical chemistry.

Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000

P. Hyltoft Petersen, P. H. Petersen, A. Lahti, 2004, Scandinavian journal of clinical and laboratory investigation.

The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties

P. Hyltoft Petersen, A. Uldall, P. H. Petersen, 2004, Scandinavian journal of clinical and laboratory investigation.

Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications

Ivan Brandslund, Per Hyltoft Petersen, Esther A Jensen, 2012, Clinical chemistry and laboratory medicine.

Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Testicular Seminoma or Nonseminoma Stage I: Two Nationwide Danish Studies of Surveillance

P. H. Petersen, M. Ro̸rth, L. Specht, 2002 .

Gender-partitioned patient medians of serum albumin requested by general practitioners for the assessment of analytical stability

P. H. Petersen, C. Fraser, G. Sölétormos, 2017, Clinical chemistry and laboratory medicine.

Models for Combining Random and Systematic Errors. Assumptions and Consequences for different Models

James O. Westgard, Sverre Sandberg, Dietmar Stöckl, 2001, Clinical chemistry and laboratory medicine.

Evaluation of growth hormone assays using ratio plots.

P. H. Petersen, C. Hagen, M. Andersen, 1998, Clinical chemistry.

Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb)

P. H. Petersen, L. Hegedüs, O. Blaabjerg, 2006, Clinical chemistry and laboratory medicine.

Hypersecretion of the alpha-subunit in clinically non-functioning pituitary adenomas: Diagnostic accuracy is improved by adding alpha-subunit/gonadotropin ratio to levels of alpha-subunit.

P. H. Petersen, J. Jørgensen, C. Hagen, 2010, Clinical and investigative medicine. Medecine clinique et experimentale.

2.3. Clinical test evaluation. Unimodal and bimodal approaches

P. H. Petersen, M. Hørder, P. Petersen, 1992 .

Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine

Sverre Sandberg, Rob Jansen, Mauro Panteghini, 2015, Clinical chemistry and laboratory medicine.

The variability of ST segment in the early phase of acute myocardial infarction.

P. H. Petersen, K. Thygesen, M. Hørder, 2009, Acta medica Scandinavica. Supplementum.

The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients

Sverre Sandberg, Per Hyltoft Petersen, Thomas Røraas, 2016, Scandinavian journal of clinical and laboratory investigation.

Haemolytic uraemic syndrome and accumulation of haemoglobin-haptoglobin complexes in plasma in serum sickness caused by penicillin drugs.

P. H. Petersen, I. Brandslund, P. Hole, 1980, Haemostasis.

Catabolism of haemoglobin-haptoglobin complexes in haemolytic uraemia-like syndromes of different etiologies.

P. H. Petersen, I. Brandslund, E. Parlev, 1982, Scandinavian journal of clinical and laboratory investigation.

Proposed guidelines for the internal quality control of analytical results in the medical laboratory.

D Stöckl, C Ricós, J C Libeer, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Laboratory process specifications for assuring quality in the U.S. National Cholesterol Education Program.

J O Westgard, P H Petersen, D A Wiebe, 1991, Clinical chemistry.

Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments

P. H. Petersen, Grete Monsen, S. Sandberg, 2012, Clinical chemistry and laboratory medicine.

Critical comments on ‘Significance of a change between two consecutive measured values’

P. H. Petersen, 2012, Scandinavian journal of clinical and laboratory investigation.

Introduction: strategies to set global quality specifications in laboratory medicine.

C G Fraser, P H Petersen, A Kallner, 1999, Scandinavian journal of clinical and laboratory investigation.

STRATEGIES TO SET GLOBAL ANALYTICAL QUALITY SPECIFICATION, IN LABORATORY MEDICINE

Anders Kallner, Callum G. Fraser, Per Hyltoft Petersen, 1999 .

Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals.

Sverre Sandberg, Thomas Røraas, P. H. Petersen, 2012, Clinical chemistry.

Appropriate sera for calibration and control of specific protein assays.

P. H. Petersen, O. Blaabjerg, M. Blom, 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.

5.3 Preparation of the Nordic Protein Calibrator

P. H. Petersen, O. Blaabjerg, M. Blom, 1994 .

A Nordic reference serum suitable for use as trueness control in the clinical routine laboratory.

P. H. Petersen, I. Penttilä, W. Gerhardt, 1993, Upsala Journal of Medical Sciences.

3. Elements of Analytical Quality

P. H. Petersen, K. Irjala, K. Bjøro, 1994 .

A double-blind study comparing sulindac with indomethacin in rheumatoid arthritis.

P. H. Petersen, H. Lund, R. Donde, 1980, Scandinavian journal of rheumatology. Supplement.

Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents.

Sverre Sandberg, Una Ø Sølvik, P. H. Petersen, 2010, Clinical chemistry.

Clinical evaluation of models and markers of myocardial ischemia.

P. H. Petersen, K. Thygesen, M. Hørder, 1983, Upsala journal of medical sciences.

Limitation of enzymatic models for predicting myocardial infarct size.

P. H. Petersen, K. Thygesen, M. Hørder, 1983, British heart journal.

Pepsinogen determinations as a possible means for evaluation of gastric acid secretion.

P. H. Petersen, C. Strande, K. Fischermann, 1971, The American journal of gastroenterology.

Standardised procedures can improve the validity of susceptibility testing of uropathogenic bacteria in general practice

P. H. Petersen, L. Bjerrum, P. Søgaard, 2000, Scandinavian journal of primary health care.

Analytical bias by contamination from hemolysis in determination of serum lactate dehydrogenase isoenzyme 1 in patients with testis germ cell tumors.

P. H. Petersen, B. No̸rgaard-Pedersen, F. V. von Eyben, 1993, Upsala Journal of Medical Sciences.

Correcting for contamination from hemolysis in measurements of lactate dehydrogenase isoenzyme 1 in serum from patients with testicular germ cell.

P. H. Petersen, F. V. von Eyben, O. Blaabjerg, 1993, Clinical Chemistry.

Performance criteria based on true and false classification and clinical outcomes. Influence of analytical performance on diagnostic outcome using a single clinical component

Per Hyltoft Petersen, P. H. Petersen, P. Petersen, 2015, Clinical chemistry and laboratory medicine.

Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality.

P. H. Petersen, I. Brandslund, J. Lassen, 1997, Clinical chemistry.

Screening for haemochromatosis: prevalence among Danish blood donors

P. H. Petersen, P. Wiggers, O. Blaabjerg, 1991, Journal of internal medicine.

Circulating immune complexes in ulcerative colitis.--II. Correlation with serum protein concentrations and complement conversion products.

P. H. Petersen, S. Svehag, H. Nielsen, 1978, Clinical and experimental immunology.

Thyroid function after resection for non-toxic goitre with special reference to thyroid lymphocytic aggregation and circulating thyroid autoantibodies.

P. H. Petersen, B. Nielsen, E. Hage, 1985, Acta endocrinologica.